share_log

4: Statement of changes in beneficial ownership of securities-Director Allen Charles W

SEC announcement ·  May 22 08:20
Summary by Futu AI
On May 16, 2024, Charles W. Allen, associated with 60 Degrees Pharmaceuticals, completed a purchase of 4,000 shares of the company's common stock. The transaction was executed at a price of $0.223 per share. Following this acquisition, Allen's direct holdings in the company increased to a total of 14,000 shares. The transaction is categorized as an exercise or conversion of derivative security, and it reflects Allen's growing stake in the pharmaceutical company.
On May 16, 2024, Charles W. Allen, associated with 60 Degrees Pharmaceuticals, completed a purchase of 4,000 shares of the company's common stock. The transaction was executed at a price of $0.223 per share. Following this acquisition, Allen's direct holdings in the company increased to a total of 14,000 shares. The transaction is categorized as an exercise or conversion of derivative security, and it reflects Allen's growing stake in the pharmaceutical company.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.